Biochemical aspects of neurodegeneration in human brain:: Involvement of neural membrane phospholipids and Phospholipases A2

被引:125
作者
Farooqui, AA
Ong, WY
Horrocks, LA
机构
[1] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA
[2] Natl Univ Singapore, Dept Anat, Singapore 119260, Singapore
关键词
phospholipases; neurodegeneration; calcium influx; apoptosis; necrosis; oxidative stress;
D O I
10.1007/s11064-004-6871-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neural membrane phospholipids are hydrolyzed by a group of enzymes known as phospholipases. This process results in the generation of second messengers such as arachidonic acid, eicosanoids, platelet activating factor, and diacylglycerols. High levels of these metabolites are neurotoxic and are associated with neurodegeneration. The collective evidence from many studies suggests that neural membrane phospholipid metabolism is disturbed in neural trauma and neurodegenerative diseases. This disturbance is caused by the stimulation of phospholipases A(2). Stimulation of these enzymes produces changes in membrane permeability, fluidity, and alteration in ion homeostasis. Low calcium influx produces mild oxidative stress and results in neurodegeneration promoted by apoptosis, whereas a calcium overload generates high oxidative stress and causes neurodegeneration associated with necrosis. Alterations in phospholipid metabolism along with the accumulation of lipid peroxides and compromised energy metabolism may be responsible for neurodegeneration in ischemia, spinal cord trauma, head injury, and Alzheimer disease. The synthesis of phospholipases A2 inhibitors that cross the blood-brain barrier without harm may be useful for the treatment of acute neural trauma and neurodegenerative diseases.
引用
收藏
页码:1961 / 1977
页数:17
相关论文
共 136 条
[41]  
Farooqui Akhlaq A., 2002, Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, V1, P193, DOI 10.2174/1568014023355917
[42]  
Farooqui Akhlaq A, 2004, Curr Drug Targets Cardiovasc Haematol Disord, V4, P85, DOI 10.2174/1568006043481239
[43]  
Fernandez MG, 2002, CELL GROWTH DIFFER, V13, P449
[44]   PREVENTION OF APOPTOTIC NEURONAL DEATH BY G(M1) GANGLIOSIDE - INVOLVEMENT OF TRK NEUROTROPHIN RECEPTORS [J].
FERRARI, G ;
ANDERSON, BL ;
STEPHENS, RM ;
KAPLAN, DR ;
GREENE, LA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (07) :3074-3080
[45]   Oxidative stress in brain aging - Implications for therapeutics of neurodegenerative diseases [J].
Floyd, RA ;
Hensley, K .
NEUROBIOLOGY OF AGING, 2002, 23 (05) :795-807
[46]   Structure, regulation, and function of phospholipase C isozymes [J].
Fukami, K .
JOURNAL OF BIOCHEMISTRY, 2002, 131 (03) :293-299
[47]   HIPPOCAMPAL EXCITATORY AMINO-ACID RECEPTORS IN ELDERLY, NORMAL INDIVIDUALS AND THOSE WITH ALZHEIMERS-DISEASE - NON-N-METHYL-D-ASPARTATE RECEPTORS [J].
GEDDES, JW ;
ULAS, J ;
BRUNNER, LC ;
CHOE, W ;
COTMAN, CW .
NEUROSCIENCE, 1992, 50 (01) :23-34
[48]   RECOVERY OF MOTOR FUNCTION AFTER SPINAL-CORD INJURY - A RANDOMIZED, PLACEBO-CONTROLLED TRIAL WITH GM-1 GANGLIOSIDE [J].
GEISLER, FH ;
DORSEY, FC ;
COLEMAN, WP .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (26) :1829-1838
[49]   Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease [J].
Guan, ZZ ;
Wang, YA ;
Cairns, NJ ;
Lantos, PL ;
Dallner, G ;
Sindelar, PJ .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1999, 58 (07) :740-747
[50]   Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry [J].
Han, XL ;
Holtzman, DM ;
McKeel, DW .
JOURNAL OF NEUROCHEMISTRY, 2001, 77 (04) :1168-1180